You are viewing an old version of this page. View the current version.
Compare with Current
View Page History
« Previous
Version 10
Next »
Discussion items
| Item | Description | Mins | Owner | Notes & Actions |
|---|
| 1 | Opening | 2 min | | Welcome & Notification of Recording |
| 2 | Hydration Subsumption (incl. less granular Clinical Drug) | 50 min | @Canada @All | - Proposal from Canada
- Group discussion on options
|
| 3 | Substances Co-Ordination Update | 8 min | Alejandro Lopez Osornio | - Combined substances sheet link has been updated: HERE.
- Update on substances in multiple extensions (circa. 80)
- Update on substances in single extensions
|
| 4 | AOB |
|
|
|
| 5 | Topic Backlog |
|
| - Hydration Subsumption
- Less Granular Clinical Drug
- Elemental Substances (Matt, AUS)
- Dose Form Intended Site v Route of Administration (BEL)
- Substances Co-ordination
- Step 1: Substances in multiple extensions
- Step 2: Substances in one extension
- Step 3: Ongoing Substance Co-ordination (capturing at regulator level)
- Medication Stopped v Medication Discontinued (Karen, SI)
- Medicinal Product promotion co-ordination (Oslo group discussion as linked to substances work)
- Value range of a |Has container type| attribute (Linda, CA)
- Drug extension MRCM attributes (CA, AUS)
- Top level children of 373873005 |Pharmaceutical / biologic product| hierarchy - are members using/how are members using? (AUS)
Group Input on Patch Strength Representation
|
| 6 |
|
|
|
|
No files shared here yet.